Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cytel announces plans for Cylexin at investors conference

Dec. 5, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

New hope for heart failure patients

Dec. 3, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

XOMA receives U.S. patents covering BPI-related products

Nov. 27, 1996

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...